Immunomorphology and molecular biology of mixed primary liver cancers: is Nestin a marker of intermediate‐cell carcinoma?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunomorphology and molecular biology of mixed primary liver cancers: is Nestin a marker of intermediate‐cell carcinoma?

Published:2019-10-29 Issue:2 Volume:76 Page:265-274
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Malvi Deborah¹,Biase Dario²,Fittipaldi Silvia¹,Grillini Marco¹,Visani Michela³,Pession Annalisa²,D'Errico Antonia¹^ORCID,Vasuri Francesco¹^ORCID

Affiliation:

1. Pathology Unit S.Orsola Malpighi Hospital Bologna University Bologna Italy

2. Department of Pharmacy and Biotechnology Molecular Pathology Unit University of Bologna Bologna Italy

3. Molecular Pathology Unit Azienda USL Bologna University Bologna Italy

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.13966

Reference35 articles.

1. Histological Typing of Tumours of the Liver

2. PRIMARY CARCINOMA OF THE LIVER

3. Combined hepatocellular cholangiocarcinoma: Controversies to be addressed

4. cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptomic profiling of intermediate cell carcinoma of the liver;Hepatology Communications;2024-08

2. Combined hepatocellular cholangiocarcinoma: A clinicopathological update;World Journal of Hepatology;2024-05-27

3. Nestin may be a candidate marker for differential diagnosis between small duct type and large duct type intrahepatic cholangiocarcinomas;Pathology - Research and Practice;2024-01

4. Current advances and future directions in combined hepatocellular and cholangiocarcinoma;Gastroenterology Report;2023-12-22

5. A One-Step Plasma Assisted Synthesis of Gold Nanoparticles and Simultaneous Linker-Free Conjugation with Nestin: An In Vitro Study of Cellular toxicity;2023-12-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3